deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

AUSTOFIX GROUP LIMITED (ASX.AYX)

ASX Announcements (courtesy of ASX)

20082009201020112012

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names

 

Shareholder links
Our website ranking of AYX: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details
Address: 18 Kinkaid Avenue, NORTH PLYMPTON, SA, AUSTRALIA, 5037
Tel:  (08) 83510644 Fax: (08) 83510855

Date first listed: 27/02/2008

Sector: Health Care Equipment & Services
Industry Group: XHJ
Activities: Designer, manufacturer and distributor of specialist medical devices

Shareholders in this company should consider crystallising a capital loss in 2023/24 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.

01/08/2023

delisted following receipt of shareholder approval at the Extraordinary General Meeting held on 14 June 2012

21/06/2012

we understand the company delisted as part of a cost reduction strategy and given the limited liquidity of AYX stock on the ASX

21/06/2012

releases Chairman's address

13/06/2012

company announces that it has entered into a Subscription Agreement with a sophisticated investor, Sedico Pty Ltd, for the issue of shares and options in the Company - a total of 952,381 shares will be issued, along with 952,381 unlisted options to acquire ordinary shares, exercisable at any time prior to 15 December 2012; ï‚· the shares will be issued for $0.21 per share, raising a total of $200,000 for the Company; ï‚· the options will be exercisable at $0.21 per option

24/05/2012

an Extraordinary General Meeting, is to be held at 10:00 a.m. on Thursday 14 June 2012 at Grant Thornton, Level 1, 67 Greenhill Road, Wayville SA 5034

14/05/2012

The Company has entered into a Subscription Agreement with Shajanamon Australia Pty Ltd as trustee for Adonai Ergon Trust for the issue shares and options in the Company - The Company has also finalised and formally entered into two non-convertible unsecured loan agreements (the Loan Agreements) with two directors of the Company

08/05/2012

the Board has determined that the delisting of the Company from the Australian Securities Exchange (the ASX) is in the best interests of shareholders as the benefits of being listed no longer outweigh the costs and disadvantages of being listed - As a result the Board has determined to put forward a resolution at an upcoming Extraordinary General Meeting (EGM) seeking shareholder approval to delist the Company" securities from quotation on the ASX

30/04/2012

The Company continues to progress discussions - now says it will be 30 April 2012 by which they will be able to make an announcement

30/03/2012

releases Half Yearly Report And Accounts

01/03/2012

The Company continues to progress discussions with a number of parties in relation to the contribution of further funds to the Company in addition to those funds raised in December 2011 and early February 2012. The Company requests that the current suspension granted by the ASX continue until 30 March 2012, unless an announcement is made regarding the outcome of these discussions prior to that date

17/02/2012

company announces that it has finalised and formally entered into non-convertible loan agreement (the Agreement) with a director of the Company. The director has advanced $250,000 (the Principal) with an interest rate of 10% compounding per annum (the Interest). The Principal and the Interest are to be paid back in a lump sum at the expiry of the Agreement on 31 December 2013

04/02/2012

The Company continues to progress discussions with a number of parties in relation to the contribution of further equity funds to the Company in addition to those funds raised in December 2011. The Company requests that the current suspension granted by the ASX continue until 20 February 2012, unless an announcement is made regarding the outcome of these discussions prior to that date

19/01/2012

company announces the appointment of Chromis Surgical Pty Ltd (Chromis Surgical) as its agent for sales of hip and trauma products, effective immediately

09/12/2011

the Company advises that discussions regarding a capital raising are ongoing and will continue beyond 25 November 2011

25/11/2011

Austofix Group Limited (ASX:AYX) (the Company) has today finalised and formally entered into non-convertible loan agreements (the Agreements) whereby directors or certain parties that are related to directors have entered into the Agreements with the Company

22/11/2011

each resolution was passed on a show of hands at the annual general meeting of the Company held today

18/11/2011

Austofix Group Limited (ASX Code: AYX) (the Company) advises that it is still in ongoing discussions regarding a capital raising

09/11/2011

the securities of Austofix Group Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company regarding a capital raising

28/10/2011
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Mark BalnavesNon Exec Chairman02/05/2006
    Mark SzolgaCEO, Investor Relations01/03/2007
    Tony IngmanExecutive Director02/05/2006
    John NielsenDirector30/11/2011
    Dion SilvyCompany Secretary
    Alexander Robert PorterCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    Date of first appointment, title may have changed.